4155 primary hepatocellular carcinoma with known diagnosis month/year

Slides:

Advertisements

Similar presentations

FEMALE BREAST CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.

Advertisements

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.

PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.

MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

LUNG CANCER Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all.

PANCREATIC CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY 2009.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

GASTRIC CANCER JHH Johns Hopkins Hospital Gastric Cancer , All Cases n=317 Analytic - Initially Diagnosed and/or received all or.

ANALYTIC LUNG CANCER by CLASS N = 351 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility.

The Burden of Cancer in Connecticut Lou Gonsalves Connecticut Tumor Registry

HEAD/NECK CARCINOMA Johns Hopkins Hospital.

JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.

1 Yize R. Wang, MD, PhD, John R. Cangemi, MD, Edward V. Loftus Jr, MD and Michael F. Picco, MD, PhD Am J Gastroenterol 2013;108:444–449 F1 김혁 / Prof. 김효종.

Date of download: 6/25/2016 From: Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic.

Supplementary Figure 1. Importance of first neighbours in breast cancer, hepatocellular carcinoma and non-small cell lung cancer in the SignaLink network.

NON-SMALL CELL LUNG CANCER

A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.

Ovarian Cancer (C56): Five-Year Relative Survival (%) by Stage, Adults Aged 15-99, Former Anglia Cancer Network Please include the citation provided.

JOHNS HOPKINS HOSPITAL CANCER REGISTRY

Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma Chi-Fu Jeffrey Yang, MD, Hanghang Wang, MD, PhD, Arvind.

Copyright © 2015 American Medical Association. All rights reserved.

Presented By Deborah Schrag at 2016 ASCO Annual Meeting

Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study Liver Cancer.

BCLC Outperforms HKLC Staging of Hepatocellular Carcinoma in Multiethnic Asians – Real-World Perspective ESPS Manuscript NO:

Cancer of the Body of the Uterus (C54):

Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment Liver.

JOHNS HOPKINS CANCER REGISTRY 2009

ANALYTIC PANCREATIC CANCER by CLASS N = 369

Johns Hopkins Hospital Cancer Registry

Testicular Cancer (C62):

Cervical Cancer (C53): Five-Year Relative Survival (%) by Stage, Adults Aged 15-99, Former Anglia Cancer Network Please include the citation.

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies Sai-Hong Ignatius Ou, MD,

Breast Cancer (C50): Five-Year Relative Survival (%) by Stage, Adults Aged 15-99, Former Anglia Cancer Network Please include the citation provided.

Bowel Cancer (C18-C20): Five-Year Relative Survival (%) by Stage, Adults Aged 15-99, Former Anglia Cancer Network Please include the citation.

Volume 146, Issue 7, Pages e3 (June 2014)

Lung Cancer Audit to patient Reference Group

4 Relative survival Ontario Cancer Statistics 2016 Chapter 4: Relative survival.

EUROPEAN LIVER TRANSPLANT REGISTRY

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Focus on hepatocellular carcinoma

Figure 2 Examples of histopathological validation

Estimated current cancer incidence

Volume 137, Issue 3, Pages e1 (September 2009)

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Volume 146, Issue 7, Pages e3 (June 2014)

Leigh Ann White, Joseph Menzin, Jonathan R

Volume 141, Issue 1, Pages e23-e26 (July 2011)

Correction Journal of the American College of Surgeons

Patients who have received chemotherapy (n=60)

Anne M. Butler, PhD, Andrew F. Olshan, PhD, Abhijit V

Treating Leukemia in Youths

Disease-specific survival

National Cancer Statistics in Korea, 2015

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Volume 64, Issue 1, Pages (July 2003)

Ellen Kim, MD, MPH, Siran Koroukian, PhD, Charles R. Thomas, MD

Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q

Caitlin C. Murphy, Kristin Wallace, Robert S. Sandler, John A. Baron

Combined data from RISC (n=3,024) and San Raffaele dataset (n=1,067)

Conditional Survival of Malignant Thymoma Using National Population-Based Surveillance, Epidemiology, and End Results (SEER) Registry (1973–2011) Ellen.

A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.

Liver Transplantation for Hepatocellular Carcinoma

GOCS GRUPO ONCOLÓGICO COOPERATIVO DEL SUR

Projected National Impact of Colorectal Cancer Screening on Clinical and Economic Outcomes and Health Services Demand Uri Ladabaum, Kenneth Song Gastroenterology

Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study Jessica A. Davila, Hashem B. El–Serag Clinical.

Lung Cancer (C33-C34): 2011 Proportion of Cases Diagnosed at Each Stage, Adults (Aged 15-99), England and Wales Stage Adults Stage I 14.5% Stage II 7.3%

Trends in survival from metastatic lung cancer in California,

Volume 156, Issue 4, Pages (March 2019)

N-Linked glycosylation of total protein from representative HCC tissue and adjacent liver tissue. N-Linked glycosylation of total protein from representative.

Trevor D. Thompson NAACCR Conference 2019 Mathematical Statistician

Presentation transcript:

6825 liver cancer cases in elderly aged >=65 years reported to SEER in 2007-2009 4155 primary hepatocellular carcinoma with known diagnosis month/year 2015 with AJCC stage I/II hepatocellular carcinoma 1768 cases with continual enrollment in Medicare Parts A and B 2670 non primary cases, non carcinoma, diagnosed at autopsy, or missing diagnosis date 2140 with stage III/IV hepatocellular carcinoma or unknown stage 247 not continually enrolled in Medicare Parts A, B 1036 cases with continual enrollment in Medicare Part D 732 not continually enrolled in Medicare Part D Supplementary Figure S1. Selection of Medicare patients diagnosed with hepatocellular carcinoma for investigation of the association of statin use and survival